Skip to main content

Validation of an in vivo translational medicine approach for the treatment of diabetes and diabetes complications

Searching for OpenAIRE data...


Diet-induced β-cell insulin resistance results in reversible loss of functional β-cell mass

Author(s): Meike Paschen, Tilo Moede, Ismael Valladolid-Acebes, Barbara Leibiger, Noah Moruzzi, Stefan Jacob, Concha F. García-Prieto, Kerstin Brismar, Ingo B. Leibiger, Per-Olof Berggren
Published in: The FASEB Journal, 2018, Page(s) fj.201800826R, ISSN 0892-6638
Publisher: Federation of American Societies for Experimental Biology
DOI: 10.1096/fj.201800826R

Intraocular in vivo imaging of pancreatic islet cell physiology/pathology

Author(s): Ingo B. Leibiger, Per-Olof Berggren
Published in: Molecular Metabolism, 6/9, 2017, Page(s) 1002-1009, ISSN 2212-8778
Publisher: Elsevier GmbH
DOI: 10.1016/j.molmet.2017.03.014

Kinetics of functional beta cell mass decay in a diphtheria toxin receptor mouse model of diabetes

Author(s): Pim P. van Krieken, Andrea Dicker, Maria Eriksson, Pedro L. Herrera, Ulf Ahlgren, Per-Olof Berggren, Erwin Ilegems
Published in: Scientific Reports, 7/1, 2017, ISSN 2045-2322
Publisher: Nature Publishing Group
DOI: 10.1038/s41598-017-12124-w

Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point

Author(s): Rayner Rodriguez-Diaz, R. Damaris Molano, Jonathan R. Weitz, Midhat H. Abdulreda, Dora M. Berman, Barbara Leibiger, Ingo B. Leibiger, Norma S. Kenyon, Camillo Ricordi, Antonello Pileggi, Alejandro Caicedo, Per-Olof Berggren
Published in: Cell Metabolism, 27/3, 2018, Page(s) 549-558.e4, ISSN 1550-4131
Publisher: Cell Press
DOI: 10.1016/j.cmet.2018.01.015